Literature DB >> 8008222

Migraine prevalence. A review of population-based studies.

W F Stewart1, A Shechter, B K Rasmussen.   

Abstract

Obtaining accurate and reliable information on the prevalence of migraine is essential to understanding the burden it places on society. Although the epidemiology of headache has been described in more than 50 population-based studies, only 24 of these have described the gender- and age-specific prevalence of migraine. Essentially five different case definitions have been used in these studies. Variation in the prevalence of migraine among studies is largely due to differences in case definition and in the age and gender distribution of study populations. Among four recent studies that used the diagnostic criteria of the International Headache Society (IHS), a coherent picture emerges. The prevalence of migraine is approximately 6% among men and 15 to 17% among women. Prevalence varies by age, increasing to about age 40 years and declining thereafter in both men and women. The gender ratio also appears to vary by age, increasing from menarche to about age 42 years and declining thereafter. Although the use of the IHS criteria has resulted in a more coherent picture across population-based studies, efforts must be made to assess the reliability and validity of these criteria in population-based samples.

Entities:  

Mesh:

Year:  1994        PMID: 8008222

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  72 in total

1.  Relationship between migraine and right-to-left shunt in children: editorial.

Authors:  Werner Budts
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

2.  Pain characteristics and pain catastrophizing in incarcerated women with chronic pain.

Authors:  Beth D Darnall; Elizabeth Sazie
Journal:  J Health Care Poor Underserved       Date:  2012-05

Review 3.  The Insula: A "Hub of Activity" in Migraine.

Authors:  David Borsook; Rosanna Veggeberg; Nathalie Erpelding; Ronald Borra; Clas Linnman; Rami Burstein; Lino Becerra
Journal:  Neuroscientist       Date:  2015-08-19       Impact factor: 7.519

4.  Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.

Authors:  Amanda Avona; Carolina Burgos-Vega; Michael D Burton; Armen N Akopian; Theodore J Price; Gregory Dussor
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

5.  Validation of the work and health interview.

Authors:  Walter F Stewart; Judith A Ricci; Carol Leotta; Elsbeth Chee
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

6.  Acupuncture is no more effective than sham acupuncture in the treatment of migraine.

Authors:  Jerry W Swanson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

Review 7.  Migraine: maladaptive brain responses to stress.

Authors:  Nasim Maleki; Lino Becerra; David Borsook
Journal:  Headache       Date:  2012-10       Impact factor: 5.887

8.  The impact of comorbid migraine on quality-of-life outcomes after endoscopic sinus surgery.

Authors:  Adam S DeConde; Jess C Mace; Timothy L Smith
Journal:  Laryngoscope       Date:  2014-02-20       Impact factor: 3.325

Review 9.  Migraine in pregnancy: what are the safest treatment options?

Authors:  V Pfaffenrath; M Rehm
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 10.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.